Wednesday, November 18, 2026 | 07:52 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Divis Laboratories Ltd News

Pharma stocks under pressure; Laurus, Sai Life, Divi's slide up to 10%

At 02:47 PM on Monday, the Nifty Pharma index was top loser among sectoral indices down 1.8% as against 0.3% rise in the Nifty 50.

Pharma stocks under pressure; Laurus, Sai Life, Divi's slide up to 10%
Updated On : 16 Nov 2026 | 3:14 PM IST

Scaling up of projects to drive gains for Divi's Labs amid strong Q2 show

Strong custom synthesis growth, improving margins and projects nearing commercialisation support Divi's Labs' outlook, though elevated valuations remain a concern for analysts

Scaling up of projects to drive gains for Divi's Labs amid strong Q2 show
Updated On : 09 Nov 2026 | 6:27 PM IST

Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%

Divi's Labs, Laurus Labs, Sai Life Sciences and Glenmark Pharma quoted at their respective record highs in Monday's trade.

Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%
Updated On : 09 Nov 2026 | 12:23 PM IST

Divis joins ₹3 trn market cap club; rallies 15% in 2 days post Q2 results

The stock price of Divi's Labs quoted higher for the 12th straight trading day, surging 32 per cent during the period.

Divis joins ₹3 trn market cap club; rallies 15% in 2 days post Q2 results
Updated On : 09 Nov 2026 | 10:02 AM IST

Divi's Labs Q2 result: Net profit rises 64% to ₹1,127 cr on higher revenue

Divi's Laboratories Ltd on Saturday posted a sharp 63.57 per cent rise in net profit to Rs 1,127 crore in the September quarter due to higher revenues. The company posted a net profit of Rs 689 crore in the corresponding period of the previous fiscal year, a regulatory filing said. Revenue from operations rose 35.39 per cent to Rs 3,676 crore during the second quarter of FY27 from Rs 2,715 crore a year earlier, it said. Its total expenses rose to Rs 2,265 crore in the period under review from Rs 1,948 crore a year ago, it added. The company's net profit for the first half of the current fiscal year, however, declined 35.39 per cent to Rs 2,029 crore from Rs 2,568 crore in the year-ago period, the filing added.

Divi's Labs Q2 result: Net profit rises 64% to ₹1,127 cr on higher revenue
Updated On : 07 Nov 2026 | 3:11 PM IST

Pharma stocks rally: Aurobindo, Divi's, Glenmark, Symbiotec hit new highs

Pharma stocks on a roll: Symbiotec Pharmalab, Windlas Biotech, Sai Life Sciences, Alembic Pharmaceuticals and Fermation Biotech were up in the range of 9-20% on Friday.

Pharma stocks rally: Aurobindo, Divi's, Glenmark, Symbiotec hit new highs
Updated On : 06 Nov 2026 | 3:15 PM IST

Adani Ports, Bosch, Divi's Labs, Marico, Welspun Living hit record highs

Indian Hotels Company, PVR Inox and Zydus Lifesciences from the BSE 500 index have hit their respective 52-week highs.

Adani Ports, Bosch, Divi's Labs, Marico, Welspun Living hit record highs
Updated On : 04 Nov 2026 | 12:33 PM IST

Breakout stocks: Chandan Taparia bets on Bharti Airtel, Paytm, Divi's Lab

Stocks to buy today: Chandan Taparia of MOFSL has shared a bullish outlook on Bharti Airtel, Paytm, and Divi's Lab.

Breakout stocks: Chandan Taparia bets on Bharti Airtel, Paytm, Divi's Lab
Updated On : 04 Nov 2026 | 7:43 AM IST

CDMO players to maintain outperformance on multiple growth triggers

Divi's Laboratories remains the top pick for most brokerages in this segment, even as valuations turn rich after the sharp rally

CDMO players to maintain outperformance on multiple growth triggers
Updated On : 04 Oct 2026 | 3:24 PM IST

Nifty may move towards 22,900, says MOFSL; shares 3 stock ideas

Nifty has to hold above the 22,700 zones for an upside move towards 22,900, then 23,000 zones, while support can be seen at 22,600.

Nifty may move towards 22,900, says MOFSL; shares 3 stock ideas
Updated On : 07 Oct 2026 | 7:46 AM IST

Robust demand, stable pricing to keep diagnostics volumes strong in FY27

Brokerages expect diagnostic majors to sustain volume growth through FY27, aided by robust demand and stable pricing, though the recent stock rally may cap upside

Robust demand, stable pricing to keep diagnostics volumes strong in FY27
Updated On : 21 Sep 2026 | 6:40 PM IST

HAL, Divis Labs among 3 stocks MOFSL's Chandan Taparia is bullish on

Till Nifty holds below 23,700, weakness could extend towards 23,500, then 23,400 levels, while on the upside, hurdles can be seen at 23,800, then 23,900 zones.

HAL, Divis Labs among 3 stocks MOFSL's Chandan Taparia is bullish on
Updated On : 09 Sep 2026 | 7:49 AM IST

Pharma shares shine: Divi's, Laurus hit new highs; zoom up to 91% in FY27

India's CRDMO sector growth rebounded to 19% YoY in Q1FY27 versus just 9% YoY in the March 2026 quarter, marking the highest growth level since the December 2024 quarter, notes Jefferies.

Pharma shares shine: Divi's, Laurus hit new highs; zoom up to 91% in FY27
Updated On : 26 Aug 2026 | 11:11 AM IST

TVS Motors, Divi's Laboratories among top stock picks by Chandan Taparia

Chandan Taparia of MOFSL recommends buying Divi's Laboratories, TVS Motors and Dixon Technologies, citing strong technical setups and improving momentum.

TVS Motors, Divi's Laboratories among top stock picks by Chandan Taparia
Updated On : 26 Aug 2026 | 7:49 AM IST

Nifty faces 24,500 hurdle; Divi's Labs, MCX, Eternal on analyst radar

Chandan Taparia of Motilal Oswal Financial Services has recommended three stocks to buy today: Divi's Laboratories, MCX, and Eternal.

Nifty faces 24,500 hurdle; Divi's Labs, MCX, Eternal on analyst radar
Updated On : 12 Aug 2026 | 7:45 AM IST

Divi's Labs rallies 5% on strong Q1; surpasses Eicher, Hindalco in mcap

In the past month, Divi's Labs outperformed the market by soaring 25 per cent, as against a 1.2 per cent rise in the BSE Sensex.

Divi's Labs rallies 5% on strong Q1; surpasses Eicher, Hindalco in mcap
Updated On : 03 Aug 2026 | 12:31 PM IST

Q1 results: Muthoot Finance, Divi's Labs, Nilkamal, and 30 more on Aug 1

Q1FY27 company results: Firms including Aarti Surfactants, Aditya Birla Lifestyle Brands, APL Apollo Tubes, and Utkarsh Small Finance Bank are also to release their April-June earnings today

Q1 results: Muthoot Finance, Divi's Labs, Nilkamal, and 30 more on Aug 1
Updated On : 01 Aug 2026 | 8:15 AM IST

Healthcare up for 4th straight month; Divis, Laurus, Torrent at new highs

The BSE Healthcare hit a new high of 51,108 on Friday, rallying 3.7% in July. The index has surged 22% since April 2026.

Healthcare up for 4th straight month; Divis, Laurus, Torrent at new highs
Updated On : 31 Jul 2026 | 3:05 PM IST

Sun Pharma, TVS Motor, Nestle, Divis among 11 BSE 500 stocks at new highs

Among others, Manappuram Finance, Marico, Radico Khaitan, Redington, Welspun Corp, Laurus Labs and Sai Life Sciences also touched respective all-time highs in trade on Thursday.

Sun Pharma, TVS Motor, Nestle, Divis among 11 BSE 500 stocks at new highs
Updated On : 30 Jul 2026 | 12:31 PM IST

Pharma index surges 2%; Torrent, Mankind, Cipla, Aurobindo soar up to 5%

Pharma stocks: RPG Life, Thyrocare, Hester Biosciences, Rubicon Research, IOL Chemicals, Emcure and Suven Life from the BSE Healthcare index rallied between 4% and 8% on Monday.

Pharma index surges 2%; Torrent, Mankind, Cipla, Aurobindo soar up to 5%
Updated On : 20 Jul 2026 | 2:43 PM IST